Cargando…

LDL in patients with subclinical hypothyroidism shows increased lipid peroxidation

BACKGROUND: Population-based studies have demonstrated that subclinical hypothyroidism (SCH) is an independent risk factor for atherosclerosis (OR = 1.9). However, this connection cannot be entirely explained by dyslipidemia accompanied by SCH. Lipid peroxidation also plays an important role in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zha, Kexi, Zuo, Changting, Wang, Aihong, Zhang, Bingchang, Zhang, Yan, Wang, Bei, Wang, Yunjia, Zhao, Jiajun, Gao, Ling, Xu, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548906/
https://www.ncbi.nlm.nih.gov/pubmed/26302822
http://dx.doi.org/10.1186/s12944-015-0092-4
_version_ 1782387240705458176
author Zha, Kexi
Zuo, Changting
Wang, Aihong
Zhang, Bingchang
Zhang, Yan
Wang, Bei
Wang, Yunjia
Zhao, Jiajun
Gao, Ling
Xu, Chao
author_facet Zha, Kexi
Zuo, Changting
Wang, Aihong
Zhang, Bingchang
Zhang, Yan
Wang, Bei
Wang, Yunjia
Zhao, Jiajun
Gao, Ling
Xu, Chao
author_sort Zha, Kexi
collection PubMed
description BACKGROUND: Population-based studies have demonstrated that subclinical hypothyroidism (SCH) is an independent risk factor for atherosclerosis (OR = 1.9). However, this connection cannot be entirely explained by dyslipidemia accompanied by SCH. Lipid peroxidation also plays an important role in the development of atherosclerosis. In this study, we aimed to evaluate oxidative stress in SCH patients, as measured according to concentrations of hydroxy-octadecadienoic acids (HODEs) and hydroxy-eicosatetraenoic acids (HETEs) in both plasma and low density lipoproteins (LDL). SUBJECTS AND METHODS: The concentrations of HODEs and HETEs in both LDL and plasma were examined in euthyroid (n = 10), mild SCH (4.5 ≤ TSH <10 mU/L, n = 10), and significant SCH (TSH ≥ 10 mU/L, n = 10) subjects, using a liquid chromatograph-electrospray ionization- mass spectrometer. Then, we explored the relationship among LDL oxidation, TSH levels, and carotid intima-media thickness (IMT), a biomarker of subclinical atherosclerosis. RESULTS: Serum LDL-C levels and mean-IMT in the significant SCH group were higher than in the euthyroid group (p < 0.05). The HODE and HETE concentrations clearly increased in the significant SCH patients compared with the euthyroid subjects, but there was no difference between the mild SCH and euthyroid groups. Among all subjects, linear and significant positive correlations were identified between TSH and mean-IMT after adjustment for confounding factors (r = 0.480, p = 0.018). Both 9-HODE (r = 0.376, p = 0.041) and 13-HODE (r = 0.447, p = 0.013) in LDL were linearly and positively correlated with TSH. The concentrations of HODEs (both 9-HODE and 13-HODE) in LDL were much higher in the thickened IMT group than in the normal IMT group (p = 0.017 and 0.015, respectively). HODEs in LDL were also positively associated with mean-IMT. CONCLUSIONS: Our findings showed that lipid peroxidation was higher in the significant SCH patients than in the euthyroid subjects, which suggested that qualitative as well as quantitative changes in serum lipids resulting from SCH may add to atherosclerosis risk. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-015-0092-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4548906
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45489062015-08-26 LDL in patients with subclinical hypothyroidism shows increased lipid peroxidation Zha, Kexi Zuo, Changting Wang, Aihong Zhang, Bingchang Zhang, Yan Wang, Bei Wang, Yunjia Zhao, Jiajun Gao, Ling Xu, Chao Lipids Health Dis Research BACKGROUND: Population-based studies have demonstrated that subclinical hypothyroidism (SCH) is an independent risk factor for atherosclerosis (OR = 1.9). However, this connection cannot be entirely explained by dyslipidemia accompanied by SCH. Lipid peroxidation also plays an important role in the development of atherosclerosis. In this study, we aimed to evaluate oxidative stress in SCH patients, as measured according to concentrations of hydroxy-octadecadienoic acids (HODEs) and hydroxy-eicosatetraenoic acids (HETEs) in both plasma and low density lipoproteins (LDL). SUBJECTS AND METHODS: The concentrations of HODEs and HETEs in both LDL and plasma were examined in euthyroid (n = 10), mild SCH (4.5 ≤ TSH <10 mU/L, n = 10), and significant SCH (TSH ≥ 10 mU/L, n = 10) subjects, using a liquid chromatograph-electrospray ionization- mass spectrometer. Then, we explored the relationship among LDL oxidation, TSH levels, and carotid intima-media thickness (IMT), a biomarker of subclinical atherosclerosis. RESULTS: Serum LDL-C levels and mean-IMT in the significant SCH group were higher than in the euthyroid group (p < 0.05). The HODE and HETE concentrations clearly increased in the significant SCH patients compared with the euthyroid subjects, but there was no difference between the mild SCH and euthyroid groups. Among all subjects, linear and significant positive correlations were identified between TSH and mean-IMT after adjustment for confounding factors (r = 0.480, p = 0.018). Both 9-HODE (r = 0.376, p = 0.041) and 13-HODE (r = 0.447, p = 0.013) in LDL were linearly and positively correlated with TSH. The concentrations of HODEs (both 9-HODE and 13-HODE) in LDL were much higher in the thickened IMT group than in the normal IMT group (p = 0.017 and 0.015, respectively). HODEs in LDL were also positively associated with mean-IMT. CONCLUSIONS: Our findings showed that lipid peroxidation was higher in the significant SCH patients than in the euthyroid subjects, which suggested that qualitative as well as quantitative changes in serum lipids resulting from SCH may add to atherosclerosis risk. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-015-0092-4) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-25 /pmc/articles/PMC4548906/ /pubmed/26302822 http://dx.doi.org/10.1186/s12944-015-0092-4 Text en © Zha et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zha, Kexi
Zuo, Changting
Wang, Aihong
Zhang, Bingchang
Zhang, Yan
Wang, Bei
Wang, Yunjia
Zhao, Jiajun
Gao, Ling
Xu, Chao
LDL in patients with subclinical hypothyroidism shows increased lipid peroxidation
title LDL in patients with subclinical hypothyroidism shows increased lipid peroxidation
title_full LDL in patients with subclinical hypothyroidism shows increased lipid peroxidation
title_fullStr LDL in patients with subclinical hypothyroidism shows increased lipid peroxidation
title_full_unstemmed LDL in patients with subclinical hypothyroidism shows increased lipid peroxidation
title_short LDL in patients with subclinical hypothyroidism shows increased lipid peroxidation
title_sort ldl in patients with subclinical hypothyroidism shows increased lipid peroxidation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548906/
https://www.ncbi.nlm.nih.gov/pubmed/26302822
http://dx.doi.org/10.1186/s12944-015-0092-4
work_keys_str_mv AT zhakexi ldlinpatientswithsubclinicalhypothyroidismshowsincreasedlipidperoxidation
AT zuochangting ldlinpatientswithsubclinicalhypothyroidismshowsincreasedlipidperoxidation
AT wangaihong ldlinpatientswithsubclinicalhypothyroidismshowsincreasedlipidperoxidation
AT zhangbingchang ldlinpatientswithsubclinicalhypothyroidismshowsincreasedlipidperoxidation
AT zhangyan ldlinpatientswithsubclinicalhypothyroidismshowsincreasedlipidperoxidation
AT wangbei ldlinpatientswithsubclinicalhypothyroidismshowsincreasedlipidperoxidation
AT wangyunjia ldlinpatientswithsubclinicalhypothyroidismshowsincreasedlipidperoxidation
AT zhaojiajun ldlinpatientswithsubclinicalhypothyroidismshowsincreasedlipidperoxidation
AT gaoling ldlinpatientswithsubclinicalhypothyroidismshowsincreasedlipidperoxidation
AT xuchao ldlinpatientswithsubclinicalhypothyroidismshowsincreasedlipidperoxidation